Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
2.090
0.00 (0.01%)
Mar 31, 2025, 10:55 AM EDT - Market open
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $11.48 million as of March 31, 2025. Its market cap has decreased by -44.65% in one year.
Market Cap
11.48M
Enterprise Value
-11.37M
1-Year Change
-44.65%
Ranking
Category
Stock Price
$2.09
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $11.48M, a decrease of -39.38%. That is a compound annual growth rate of -16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 11.48M | -35.81% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.25B |
| UnitedHealth Group | 474.64B |
| Johnson & Johnson | 394.84B |
| AbbVie | 357.09B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 227.92B |
| Merck & Co. | 225.26B |
| AstraZeneca | 225.00B |